Global Infertility Testing and Treatment Market Forecast 2019-2027
Agenda
Key Findings Market Insights
Regional Insights
Competitive Insights
Left Image Slide Many desktop publishing packages and web page editors now use Lorem Ipsum as their default model text, and a search for 'lorem ipsum' will uncover many web sites still in their infancy. Various versions have evolved.
Key Findings • Infertility is defined as the inability of a couple to conceive naturally after at least one year of regular unprotected sexual intercourse. It remains a major clinical and social problem, affecting perhaps every one couple out of six. Evaluation usually begins post 12 months; however, it may be indicated earlier depending on the case. • Global infertility testing and treatment market are estimated to grow with approx. 6.39% CAGR during the year 2019-2027. The base year considered for the study is 2018 and the forecast period is 20192027. • The rise in infertility and treatment awareness and the introduction of new testing devices is fueling growth in global infertility testing and treatment market.
Market Insights • The global infertility testing and treatment market are primarily driven because of the advances in healthcare where there has been the availability of fine-tuned fertility treatment. • Physiological causes that may cause infertility are a tubal blockage, congenital malformation, abnormal ovulation, low quality and quantity of sperm and ejaculatory dysfunctions. • Additionally, infection, higher age, pollution, and other environmental hazards may lead to infertility. • Moreover, increasing success rates of IVF is encouraging the patients to undergo the treatment. Despite various motivators, the market is experiencing a slower growth rate due to the high cost of treatment.
Image Slide
Lorem Ipsum
Lorem Ipsum
Lorem Ipsum
Lorem Ipsum
Lorem Ipsum
Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.
Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.
Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.
Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.
Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.
The Global Infertility Testing and Treatment Market is estimated to grow with 6.39% CAGR during the forecasting year of 2019-2027. Request Free Sample
Request Free Sample
The North America Infertility Testing and Treatment Market is expected to expand with a CAGR of 6.07% during the forecast period 2019-2027.
Request Free Sample
The Europe Infertility Testing and Treatm ent Market is anticipated to rise with a CAGR of 6.12% during the forecast period 20192027.
The Asia Pacific Infertility Testing and Treatm ent Market is anticipated to rise with a CAGR of 7.06% during the forecast period of 2019-2027.
Request Free Sample
Competitive Insights The eminent companies operating in the market that are profiled in the report are Ferring Pharmaceuticals, Progyny, Thermo Fisher Scientific Inc., Genea, Ovascience, The Cooper Companies, Inc., Andrology Solutions, Merck, Esco Micro PTE. Ltd., Halotech DNA, Irvine Scientific, Vitrolife AB, Origio, Quest Diagnostic, and Endo Pharmaceuticals. These companies depend on many organic and inorganic strategies for their expansion.